Low-dose IL-2 enhances the generation of IL-10-producing immunoregulatory B cells. (2023)
Attributed to:
Low dose interleukin (IL)-2 in patients with a recent acute coronary syndrome
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1038/s41467-023-37424-w
PubMed Identifier: 37045832
Publication URI: http://europepmc.org/abstract/MED/37045832
Type: Journal Article/Review
Volume: 14
Parent Publication: Nature communications
Issue: 1
ISSN: 2041-1723